Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Single Agent Adjuvant Trastuzumab (Herceptin®) in Older Women With Early-Stage and Locally Advanced Breast Cancer: A Phase II Trial

NCT00796978 is registered in ClinicalTrials.gov with Cynthia Owusu, MD as lead sponsor.

NCT NCT00796978
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00796978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Single Agent Adjuvant Trastuzumab (Herceptin®) in Older Women With Early-Stage and Locally Advanced Breast Cancer: A Phase II Trial
Lead sponsor
Cynthia Owusu, MD
Phase
Phase 2
Overall status
Completed
Start date
February 5, 2009
Completion date
February 26, 2020
Enrollment
56 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer